129 related articles for article (PubMed ID: 15746533)
1. Tissue transglutaminase (TG2) in cancer biology.
Mangala LS; Mehta K
Prog Exp Tumor Res; 2005; 38():125-38. PubMed ID: 15746533
[No Abstract] [Full Text] [Related]
2. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
3. Tissue transglutaminase in tumour progression: friend or foe?
Kotsakis P; Griffin M
Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer.
Mehta K; Kumar A; Kim HI
Biochem Pharmacol; 2010 Dec; 80(12):1921-9. PubMed ID: 20599779
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
Agnihotri N; Mehta K
Amino Acids; 2017 Mar; 49(3):425-439. PubMed ID: 27562794
[TBL] [Abstract][Full Text] [Related]
7. Tissue transglutaminase 2 promotes apoptosis of rat neonatal cardiomyocytes under oxidative stress.
Song H; Kim BK; Chang W; Lim S; Song BW; Cha MJ; Jang Y; Hwang KC
J Recept Signal Transduct Res; 2011 Feb; 31(1):66-74. PubMed ID: 21067463
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications.
Collighan RJ; Griffin M
Amino Acids; 2009 Apr; 36(4):659-70. PubMed ID: 18982407
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 in the balance of cell death and survival.
Fésüs L; Szondy Z
FEBS Lett; 2005 Jun; 579(15):3297-302. PubMed ID: 15943974
[TBL] [Abstract][Full Text] [Related]
11. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of transglutaminase 2 under different oxidative stress conditions.
Caccamo D; Currò M; Ferlazzo N; Condello S; Ientile R
Amino Acids; 2012 Feb; 42(2-3):1037-43. PubMed ID: 21805137
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
Park D; Choi SS; Ha KS
Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
[TBL] [Abstract][Full Text] [Related]
16. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
[TBL] [Abstract][Full Text] [Related]
17. Some lessons from the tissue transglutaminase knockout mouse.
Sarang Z; Tóth B; Balajthy Z; Köröskényi K; Garabuczi E; Fésüs L; Szondy Z
Amino Acids; 2009 Apr; 36(4):625-31. PubMed ID: 18584284
[TBL] [Abstract][Full Text] [Related]
18. Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer.
Mehta K
Amino Acids; 2009 Apr; 36(4):709-16. PubMed ID: 18594944
[TBL] [Abstract][Full Text] [Related]
19. Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network.
Zhang H; McCarty N
Autophagy; 2017 Mar; 13(3):627-628. PubMed ID: 28056186
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Di Giacomo G; Lentini A; Beninati S; Piacentini M; Rodolfo C
Amino Acids; 2009 Apr; 36(4):717-24. PubMed ID: 18594948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
